Intracavitary brachytherapy significantly enhances local control of early T-stage nasopharyngeal carcinoma: The existence of a dose-tumor-control relationship above conventional tumoricidal dose
Pml. Teo et al., Intracavitary brachytherapy significantly enhances local control of early T-stage nasopharyngeal carcinoma: The existence of a dose-tumor-control relationship above conventional tumoricidal dose, INT J RAD O, 46(2), 2000, pp. 445-458
Citations number
33
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Onconogenesis & Cancer Research
Journal title
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Purpose: To study the efficacy of intracavitary brachytherapy (ICT) in earl
y T-stage nasopharyngeal carcinoma (NPC).
Methods and Materials: All T1 and T2 (nasal infiltration) NPC treated with
a curative intent from 1984 to 1996 were analyzed (n = 509), One hundred si
xty-three patients were given ICT after radical external radiotherapy (ERT)
(Group A). They were compared with 346 patients treated by ERT alone (Grou
p B), The ERT delivered the tumoricidal dose (uncorrected BED-10 greater th
an or equal to 75 Gy) to the primary tumor and did not differ between the t
wo groups in technique or dosage. The ICT delivered a dose of 18-24 Gy in 3
fractions over 15 days to a point 1 cm perpendicular to the midpoint of th
e plane of the sources, ICT was used to treat local persistence diagnosed a
t 4-6 weeks after ERT (n = 101) or as an adjuvant for the complete responde
rs to ERT (n = 62).
Results: The two groups did not differ in patients' age or sex, rate of dis
tant metastasis, rate of regional failure, overall survival, or the follow-
up duration. However, Group A had significantly more T2 lesions and Group B
had significantly more advanced N-stages, Local failure was significantly
less (crude rates 6.75% vs. 13.0%; 5-year actuarial rates 5.40% vs. 10.3%)
and the disease-specific mortality was significantly lower (crude rates 14.
1% vs. 21.7%; 5-year actuarial rates 11.9% vs. 16.4%) in Group A compared t
o Group B, Multivariate analysis showed that the ICT was the only significa
nt prognostic factor predictive for fewer local failures (Cox regression p
= 0.0328, risk ratio = 0.49, 95% confidence interval (95% CI) = 0.256-0.957
). However, when ICT was excluded from the Cox regression model, the total
physical dose or the total BED-10 uncorrected for tumor repopulation during
the period of radiotherapy became significant in predicting ultimate local
failure rate. The two groups were comparable in the incidence rates of eac
h individual chronic radiation complication and the actuarial cumulative ra
te of the chronic radiation complications, with the exception of chronic ra
diation nasopharyngeal ulceration/necrosis which occurred in 10 patients in
Group A and 1 patient in Group B, Headache (n = 4) and foul smell (n = 8)
consequential to ulceration/necrosis were mild and manageable by conservati
ve means. A significant dose-tumor-control relationship existed when local
failure was studied as a function of the total physical dose or the total b
iological equivalent dose (linear quadratic equation, alpha/beta = 10) unco
rrected for tumor repopulation during the time course of the radiotherapy.
Conclusions: Supplementing ERT which delivered tumoricidal dose (uncorrecte
d BED-10 greater than or equal to 75 Gy), ICT significantly enhanced ultima
te local control and avoided the necessity for morbid salvage treatments in
early T-stage (T1/T2 nasal infiltration) NPC, The slight increase in chron
ic radiation ulceration/necrosis after ICT was acceptable with mild and man
ageable symptoms, Other late complications were not increased. A significan
t dose-tumor-control relationship exists above the conventional tumoricidal
dose level. (C) 2000 Elsevier Science Inc.